ClinicalTrials.Veeva

Menu

Study of High Risk Non Invasive Prenatal Test Population

C

Central Hospital, Nancy, France

Status

Unknown

Conditions

Trisomy 21

Treatments

Biological: Prenatal test for Trisomy 21 screening

Study type

Observational

Funder types

Other

Identifiers

NCT04737070
2020PI310

Details and patient eligibility

About

The investigator want to study the population of high risk (over 1/50) of Trisomy 21.

According to french guidelines, these patients needs to have a invasive test (such as amniocentesis) but some patients prefer to have a Non Invasive Prenatal Test, with a potential lack of information.

Enrollment

150 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Prenatal screening of Trisomy 21 > 1/50 (high risk population)

Exclusion criteria

  • No exclusion criteria

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems